Relmada Therapeutics, Inc. (RLMD)
7.035
+0.70
(+10.96%)
USD |
NASDAQ |
May 19, 16:00
7.035
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics EPS Diluted (TTM) : -1.112 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Theravance Biopharma, Inc. | 2.205 |
| AN2 Therapeutics, Inc. | -1.104 |
| Corcept Therapeutics, Inc. | 0.35 |
| Assertio Holdings, Inc. | -5.733 |
| Johnson & Johnson | 8.649 |